C4 Therapeutics, Inc. (CCCC) Ownership

$1.25

$0.07 (-5.3%)
Last update: 04:00 PM EST
Day's range
$1.21
Day's range
$1.29

C4 Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
LYNX1 CAPITAL MANAGEMENT LP 05/15/2025 7.10 M $11.36 M   3.58% 10.23%
SOLEUS CAPITAL MANAGEMENT, L.P. 05/15/2025 6.98 M $11.17 M   0.00% 10.06%
ORBIMED ADVISORS LLC 05/15/2025 6.83 M $10.93 M   56.02% 9.85%
WASATCH ADVISORS LP 05/15/2025 6.72 M $10.76 M   10.73% 9.69%
BLACKROCK, INC. 05/02/2025 5.28 M $8.46 M   -4.94% 7.62%
MORGAN STANLEY 05/15/2025 4.05 M $6.47 M   5.36% 5.83%
VANGUARD GROUP INC 05/09/2025 3.37 M $5.39 M   0.74% 4.86%
SAMLYN CAPITAL, LLC 05/15/2025 3.02 M $4.82 M   -0.14% 4.35%
BANK OF AMERICA CORP /DE/ 05/15/2025 1.99 M $3.19 M   18.67% 2.87%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2025 1.55 M $2.48 M   0.00% 2.23%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 1.43 M $2.29 M   3.56% 2.06%
ARROWMARK COLORADO HOLDINGS LLC 05/15/2025 1.29 M $2.06 M   -3.55% 1.85%
STATE STREET CORP 05/15/2025 1.22 M $1.96 M   0.11% 1.77%
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC 05/15/2025 1.11 M $1.78 M   0.00% 1.60%
TANG CAPITAL MANAGEMENT LLC 05/15/2025 900.00 K $1.44 M   0.00% 1.30%
SILVERARC CAPITAL MANAGEMENT, LLC 05/14/2025 882.30 K $1.41 M   -27.75% 1.27%
TWO SIGMA ADVISERS, LP 05/15/2025 800.60 K $1.28 M   -9.47% 1.15%
JACOBS LEVY EQUITY MANAGEMENT, INC 05/15/2025 697.65 K $1.12 M   100.00% 1.01%
GOLDMAN SACHS GROUP INC 05/16/2025 622.72 K $996.35 K   8.55% 0.90%
WELLS FARGO & COMPANY/MN 05/13/2025 523.62 K $837.79 K   1,342.24% 0.75%
TWO SIGMA INVESTMENTS, LP 05/15/2025 514.60 K $823.37 K   -8.73% 0.74%
DIMENSIONAL FUND ADVISORS LP 05/13/2025 514.16 K $823.23 K   -1.87% 0.74%
NORTHERN TRUST CORP 05/13/2025 499.77 K $799.63 K   0.95% 0.72%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 474.84 K $759.75 K   -2.37% 0.68%
SG AMERICAS SECURITIES, LLC 04/15/2025 425.10 K $680.00 K   100.00% 0.61%
ATOM INVESTORS LP 05/15/2025 268.83 K $430.13 K   164.38% 0.39%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2025 236.86 K $378.97 K   20.56% 0.34%
HENNION & WALSH ASSET MANAGEMENT, INC. 04/10/2025 218.41 K $349.46 K   -3.85% 0.31%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 214.50 K $343.20 K   100.00% 0.31%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 05/14/2025 212.00 K $339.21 K   95.10% 0.31%
LPL FINANCIAL LLC 05/07/2025 193.91 K $310.26 K   175.73% 0.28%
FMR LLC 05/12/2025 193.75 K $310.00 K   -11.27% 0.28%
05/12/2025 192.42 K $307.88 K   100.00% 0.28%
MARINER, LLC 05/15/2025 180.37 K $289.24 K   7.38% 0.26%
AMERICAN CENTURY COMPANIES INC 05/13/2025 141.99 K $227.18 K   6.89% 0.20%
BANK OF NEW YORK MELLON CORP 04/29/2025 141.28 K $226.05 K   0.14% 0.20%
AQR CAPITAL MANAGEMENT LLC 05/15/2025 140.53 K $224.85 K   957.59% 0.20%
INVESCO LTD. 05/12/2025 139.49 K $223.18 K   101.59% 0.20%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2025 129.90 K $207.84 K   100.00% 0.19%
BARCLAYS PLC 05/15/2025 107.52 K $172.00 K   -12.13% 0.16%
SHAY CAPITAL LLC 05/15/2025 93.41 K $149.46 K   100.00% 0.13%
RHUMBLINE ADVISERS 05/29/2025 89.63 K $143.41 K   -10.38% 0.13%
OXFORD ASSET MANAGEMENT LLP 05/15/2025 86.22 K $137.96 K   100.00% 0.12%
MAN GROUP PLC 05/15/2025 85.62 K $137.00 K   100.00% 0.12%
VIENNA POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. VIENNA INSURANCE GROUP 05/05/2025 85.00 K $136.00 K   0.00% 0.12%
D. E. SHAW & CO., INC. 05/15/2025 79.28 K $126.84 K   3.66% 0.11%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 73.78 K $118.05 K   66.84% 0.11%
MILLENNIUM MANAGEMENT LLC 05/15/2025 65.90 K $105.44 K   -81.70% 0.10%
INTECH INVESTMENT MANAGEMENT LLC 05/20/2025 53.61 K $85.77 K   77.80% 0.08%
ALLIANCEBERNSTEIN L.P. 05/15/2025 47.80 K $76.48 K   0.00% 0.07%

C4 Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 140 institutional investors and hedge funds held shares of C4 Therapeutics, Inc.. The most heavily invested institutionals were:

Lynx1 Capital Management LP: 7.1 M

Soleus Capital Management, L.P.: 6.98 M

ORBIMED ADVISORS LLC: 6.83 M

WASATCH ADVISORS LP: 6.72 M

BlackRock, Inc.: 5.28 M

MORGAN STANLEY: 4.05 M

92.40% of C4 Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 68.63 M shares in the last 24 months. This purchase volume represents approximately $85.79 M in transactions.